SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Mac who wrote (126)4/8/1998 8:26:00 PM
From: Jim Mac   of 413
 
This Q, ending April, LVCI should have about $6M U.S. procedure revenue. That puts them at break-even. Therefore, since LVCI should be able to add at least another $6M to top line per Q within a year (especially with hyperopia), and 2/3 of that can hit bottom line after PPP/Visx license fees subtracted and before taxes, assuming SGA fairly flat, gives at least $0.25 Q EPS for April Q 1999, after taxes. That's triple-digit EPS growth all year 1999 vs 1998, putting LVCI easily at $30+ by end 1999. This EXCLUDES acquisitions and new contracts. LT, looks cheap at $10.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext